TSPO and Alzheimer disease: We analyzed data from 165 patients in the AD continuum with available imaging data on neuroinflammation (proxied by translocator protein (TSPO) positron emission tomography [PET]) together with proteomic data on plasma and cerebrospinal fluid (CSF), using Olink technology targeting 368 inflammation‐related proteins.